AMDA leadership weighs in on DEA’s telehealth medicine rules debate
By
Jessica R. Towhey
Aaron Dorman
Aug 10, 2023
The DEA may re-evaluate its rules on prescribing controlled substances via telehealth appointments, following a deluge of 38,000 public comments on the initial rulemaking.
DEA extends telehealth prescription allowances through 2024
By
Aaron Dorman
Oct 11, 2023
For the second time this year, the DEA is extending telehealth prescription options, a move LTC providers say is essential for hospice care.
Palliative telecare team aids QOL, health status for chronic conditions
Jan 23, 2024
The findings were for veterans with chronic obstructive pulmonary disease, heart failure or interstitial lung disease.